Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Alpha Psychiatry ; 25(3): 407-412, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-39148598

RESUMEN

Objective: To study the clinical effect of group cognitive behavioral therapy to one-on-one treatment on patients with early-onset schizophrenia. Methods: Totally,133 patients with early-onset schizophrenia admitted to the Department of Psychiatry of our hospital from September 2020 to September 2023 were selected and divided into a control group and an observation group according to whether group behavioral cognitive therapy was performed. The general demographic data of the patients were collected, and the propensity score matching method was used to balance the baseline data of the 2 groups. The Positive and negative syndrome scale, Personal and Social Performance Scale, severity of illness (SI), and efficacy index (EI) were compared between the 2 groups after matching. Results: After matching, 72 patients were included in our study. Compared to the control group, observation group PANSS score were decreased including after intervention (P > .05). Both groups showed a decrease between before and after treatments. Positive and Negative Syndrome Scale reduction rate after treatment and total response rate were increased in the observation group (P <.001). Personal and Social Performance Scale of the Clinical Global Impression (CGI) scores were higher than those of the control group. In the CGI scores, there is a significant difference that SI scores were lower in the observation group (P = .002), while EI scores were higher (P <.001). Conclusion: Group cognitive behavioral therapy is beneficial to the improvement of mental symptoms and disease severity, social function, and curative effect, which is advocated and popularized.

2.
ACS Appl Mater Interfaces ; 15(8): 11244-11258, 2023 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-36791272

RESUMEN

The emerging intelligent piezoresistive yarn/textile-based sensors are of paramount importance for skin-interface electronics, owing to their unparalleled features including softness, breathability, and easy integration with functional devices. However, employing a facile way to fabricate 1D sensing yarns with mechanical robustness, multi-functional integration, and comfortability is still demanded for satisfying the practical applications. Herein, a facile one-step synchronous conjugated electrospinning and electrospraying technique is innovatively employed to continuously construct an Ag NW-embedded polyurethane (PU) nanofiber sensing yarn (AENSY) with hierarchical architecture. This 1D AENSY with weavability and stretchability can be woven into AENSY textile-based sensors integrated with functions of strain and pressure sensing. In this embedded multi-scale architecture, Ag NWs are evenly embedded and locked in the oriented and twisted PU nanofiber (PUNF) scaffold, forming the hierarchical mechanical sensing layer on the surface of the AENSY with favorable stability. Meanwhile, the presence of the elastic PUNFs enhances porosity, elasticity, and considerable deformation space, which in turn endow the AENSY textile-based sensor with a gauge factor (GF) up to 1010, a pressure sensitivity up to 16.7 N-1, high stretchability up to 160%, and high stability under long-term cycles. In addition, the AENSY textile-based sensor exhibits light weight and the unique advantage of skin-friendliness with the human body, which can be directly and conformally attached to the curved human skin to monitor the various human movements. Furthermore, the weavable AENSYs can be integrated into smart textiles with sensing arrays, which are capable for spatial pressure and strain mapping. Thus, the continuous one-step developing process and the stable embedded-twisted fiber structure provide a promising strategy to develop innovative smart yarns and textiles for personalized healthcare and human-machine interfaces.

3.
J Biol Chem ; 288(1): 306-18, 2013 Jan 04.
Artículo en Inglés | MEDLINE | ID: mdl-23166329

RESUMEN

Neurokinin-1 receptor (NK1R) occurs naturally on human glioblastomas. Its activation mediates glioma cell proliferation. However, it is unknown whether NK1R is directly involved in tumor cell migration. In this study, we found human hemokinin-1 (hHK-1), via NK1R, dose-dependently promoted the migration of U-251 and U-87 cells. In addition, we showed that hHK-1 enhanced the activity of MMP-2 and the expression of MMP-2 and MT1-matrix metalloproteinase (MMP), which were responsible for cell migration, because neutralizing the MMPs with antibodies decreased cell migration. The involved mechanisms were then investigated. In U-251, hHK-1 induced significant calcium efflux; phospholipase C inhibitor U-73122 reduced the calcium mobilization, the up-regulation of MMP-2 and MT1-MMP, and the cell migration induced by hHK-1, which meant the migration effect of NK1R was mainly mediated through the G(q)-PLC pathway. We further demonstrated that hHK-1 boosted rapid phosphorylation of ERK, JNK, and Akt; inhibition of ERK and Akt effectively reduced MMP-2 induction by hHK-1. Meanwhile, inhibition of ERK, JNK, and Akt reduced the MT1-MMP induction. hHK-1 stimulated significant phosphorylation of p65 and c-JUN in U-251. Reporter gene assays indicated hHK-1 enhanced both AP-1 and NF-κB activity; inhibition of ERK, JNK, and Akt dose-dependently suppressed the NF-κB activity; only the inhibition of ERK significantly suppressed the AP-1 activity. Treatment with specific inhibitors for AP-1 or NF-κB strongly blocked the MMP up-regulation by hHK-1. Taken together, our data suggested NK1R was a potential regulator of human glioma cell migration by the up-regulation of MMP-2 and MT1-MMP.


Asunto(s)
Neoplasias Encefálicas/metabolismo , Regulación Enzimológica de la Expresión Génica , Regulación Neoplásica de la Expresión Génica , Regulación de la Expresión Génica , Glioma/metabolismo , Metaloproteinasa 14 de la Matriz/metabolismo , Metaloproteinasa 2 de la Matriz/metabolismo , Receptores de Neuroquinina-1/metabolismo , Regulación hacia Arriba , Línea Celular Tumoral , Movimiento Celular , AMP Cíclico/metabolismo , Humanos , FN-kappa B/metabolismo , Péptidos/química , Taquicininas/metabolismo , Factor de Transcripción AP-1/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA